Cardiac Inflammation Research Group
11 – 20 of 35
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Long-Term Clinical Outcomes After IFR- vs FFR-Guided Coronary Revascularization : Insights From the SWEDEHEART National Registry
- Contribution to journal › Article
- 2024
-
Mark
Reply to “Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients”
- Contribution to journal › Letter
-
Mark
Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction
- Contribution to journal › Article
-
Mark
A study of size-selective renal elimination using a novel human model
- Contribution to journal › Article
-
Mark
The Gly82Ser polymorphism in the receptor for advanced glycation endproducts increases the risk for coronary events in the general population
- Contribution to journal › Article
-
Mark
Mechanistic and therapeutic studies in cardiac inflammation
(2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Special Issue “COVID-19 Coagulopathy: Advances on Pathophysiology and Therapies”
- Contribution to journal › Debate/Note/Editorial
-
Mark
Increasing plasma calprotectin (S100A8/A9) is associated with 12-month mortality and unfavourable functional outcome in critically ill COVID-19 patients
- Contribution to journal › Article
-
Mark
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-Aged individuals
- Contribution to journal › Article
-
Mark
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function : a pre-specified quality of life sub-study from the REDUCE-AMI trial
- Contribution to journal › Article
